SCHEMBL4508358

SCHEMBL4508358

COC(=O)c1cc(C(=O)c2c(C)c(OC)c3c(OCC(=O)NCCCCCCCCCCCNC(=O)COc4cccn5c(C(=O)c6ccc(N)c(C(=O)OC)c6)c(C)c(OC)c45)cccn23)ccc1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSD P07339 1/20 0.39
▸ HSD17B10 Q99714 3/20 0.36
▸ MAPT P10636 5/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ TSHR P16473 2/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ PKM P14618 1/20 0.36
▸ KMT2A Q03164 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ HDAC3 O15379 3/20 0.34
▸ HDAC1 Q13547 3/20 0.34
▸ TUBB4A P04350 1/20 0.34
▸ TUBB P07437 1/20 0.34
▸ TUBA3C P0DPH7 1/20 0.34
▸ HDAC4 P56524 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4496523 0.93 CTSD (0.39) CTSDHSD17B10MAPTALDH1A1TSHR
SCHEMBL13918689 0.93 MAPT (0.38) HSD17B10MAPTALDH1A1TSHRKMT2A
SCHEMBL4507727 0.89 PLA2G1B (0.40) CTSDHSD17B10MAPTALDH1A1TSHR
SCHEMBL13918690 0.87 MEN1 (0.38) HSD17B10MAPTALDH1A1TSHRKMT2A
SCHEMBL4516628 0.85 KDM4E (0.37) HSD17B10MAPTALDH1A1TSHRL3MBTL1
SCHEMBL13918695 0.85 KDM4E (0.37) HSD17B10MAPTALDH1A1TSHRL3MBTL1
SCHEMBL4501050 0.84 MEN1 (0.36) HSD17B10MAPTALDH1A1TSHRKMT2A
SCHEMBL4496560 0.83 HPGD (0.41) HSD17B10MAPTALDH1A1TSHRL3MBTL1
SCHEMBL4508361 0.83 L3MBTL1 (0.38) CTSDHSD17B10MAPTALDH1A1TSHR
SCHEMBL13932936 0.82 KDM4E (0.35) HSD17B10MAPTALDH1A1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 — — US disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS FGF2, FGFR1, FGF1 CTSD 1486/4885HSD17B10 2756/4885MAPT 3588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback